In the past several decades, nanosized drug delivery systems with various targeting functions and controlled drug release capabilities inside targeted tissues or cells have been intensively studied. Understanding their pharmacokinetic properties is crucial for the successful transition of this research into clinical practice. Among others, fluorescence imaging has become one of the most commonly used imaging tools in pre-clinical research. The development of increasing numbers of suitable fluorescent dyes excitable in the visible to near-infrared wavelengths of the spectrum has significantly expanded the applicability of fluorescence imaging. This paper focuses on the potential applications and limitations of non-invasive imaging techniques in the field of drug delivery, especially in anticancer therapy. Fluorescent imaging at both the cellular and systemic levels is discussed in detail. Additionally, we explore the possibility for simultaneous treatment and imaging using theranostics and combinations of different imaging techniques, e.g., fluorescence imaging with computed tomography.

Institute of Macromolecular Chemistry AS CR v v i Heyrovský Sq 2 162 06 Prague 6 Czech Republic

Martin Luther University Halle Wittenberg Dept of Internal Medicine 4 Oncology Hematology 06120 Halle Germany

Martin Luther University Halle Wittenberg Dept of Pharmacy Pharmaceutical Technology and Biopharmacy 06120 Halle Germany

Martin Luther University Halle Wittenberg Dept of Pharmacy Pharmaceutical Technology and Biopharmacy 06120 Halle Germany; Martin Luther University Halle Wittenberg Dept of Internal Medicine 4 Oncology Hematology 06120 Halle Germany

Citace poskytuje Crossref.org

Fluorescence Imaging as a Tool in Preclinical Evaluation of Polymer-Based Nano-DDS Systems Intended for Cancer Treatment